These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 15385088)

  • 1. Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps.
    Duncan RE; El-Sohemy A; Archer MC
    J Pharmacol Toxicol Methods; 2004; 50(2):139-43. PubMed ID: 15385088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.
    Patel DD; Knight BL
    Eur J Biochem; 1985 Nov; 153(1):117-23. PubMed ID: 4065145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids.
    El-Sohemy A; Archer MC
    Cancer Res; 1997 Sep; 57(17):3685-7. PubMed ID: 9288773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary factors and the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for breast cancer and development.
    Duncan RE; El-Sohemy A; Archer MC
    Mol Nutr Food Res; 2005 Feb; 49(2):93-100. PubMed ID: 15617098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of rat liver 3-hydroxy-3-methylglutaryl-CoA reductase activity by reversible phosphorylation.
    Beg ZH; Brewer HB
    Fed Proc; 1982 Aug; 41(10):2634-8. PubMed ID: 6286363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate and cholesterol in isolated rat hepatocytes during perinatal development.
    Leoni S; Mangiantini MT; Spagnuolo S; Valbonesi M; Conti Devirgiliis L; Trentalance A
    Cell Mol Biol; 1986; 32(3):243-6. PubMed ID: 3742535
    [No Abstract]   [Full Text] [Related]  

  • 8. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
    Buechler RD; Peffley DM
    Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age changes in the activity of liver 3-hydroxy-3-methylglutaryl-CoA reductase in female rats: influence of mammary pathology.
    Polo M; García-Bravo M; Igal A; Dumm IN; Goya RG
    Mech Ageing Dev; 1998 Jan; 100(1):41-51. PubMed ID: 9509393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term regulation of hydroxymethylglutaryl coenzyme A reductase by reversible phosphorylation: modulation of reductase phosphatase in rat hepatocytes.
    Gibson DM; Parker RA; Stewart CS; Evenson KJ
    Adv Enzyme Regul; 1982; 20():263-83. PubMed ID: 7051770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of HMG-CoA reductase induced by mevalonate accelerates its rate of degradation in isolated rat hepatocytes.
    Marrero PF; Haro D; Hegardt FG
    FEBS Lett; 1986 Mar; 197(1-2):183-6. PubMed ID: 3512302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in Morris hepatoma 7800 after intravenous injection of mevalonic acid.
    George R; Goldfarb S
    Cancer Res; 1980 Dec; 40(12):4717-21. PubMed ID: 7438103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
    Elfakhani M; Torabi S; Hussein D; Mills N; Verbeck GF; Mo H
    Exp Biol Med (Maywood); 2014 Mar; 239(3):293-301. PubMed ID: 24477821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the regulatory factors of 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA reductase) activity].
    Ozasa S
    Hokkaido Igaku Zasshi; 1976 Jul; 51(4):313-25. PubMed ID: 187533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse uterine epithelial cells.
    Leijten L; Wilce PA; Davidson M; Banks M; Martin L
    Biochem J; 1987 Jan; 241(1):279-84. PubMed ID: 3032158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor.
    Deng L; Ding Y; Peng Y; Wu Y; Fan J; Li W; Yang R; Yang M; Fu Q
    Bone; 2014 Oct; 67():200-7. PubMed ID: 25019595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mevalonate requirement for maintenance of fatty acid and protein synthesis during hormonally stimulated development of mammary gland in vitro.
    Middleton B; Hatton J; White DA
    J Biol Chem; 1984 Aug; 259(16):10124-8. PubMed ID: 6381480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.
    Golper TA; Feingold KR; Fulford MH; Siperstein MD
    J Lipid Res; 1986 Oct; 27(10):1044-51. PubMed ID: 3794548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of plasma mevalonate in rats and humans.
    Kopito RR; Weinstock SB; Freed LE; Murray DM; Brunengraber H
    J Lipid Res; 1982 May; 23(4):577-83. PubMed ID: 7097123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.